downstream business in Integrated Oxides and Derivatives based out of advantaged Gulf Coast USA. Indorama Ventures 2nd Quarter 2019 MD&A 2 2Q 2019 Summary Financials Table 1: Core Financials of Consolidated
relevant to its core or non-core businesses upon conditions that they have an apparent outsourcing policy, measures, criteria, and service provider control system. Outsourcing however does not discharge
system and IT security. Guidelines for operating non-core businesses are also open to public comments.The consultation paper is available at www.sec.or.th. Stakeholders and interested parties are welcome
, Structural Improvements, Enhanced Portfolio, New Investment Strategy In 2018: Revenue $10.7 billion, +27% YoY Core EBITDA of $1.4 billion, +44% YoY, Core EBITDA margin 13% Net Profit (after Tax/NCI) of
hemodialysis center. Medical Vision Co., Ltd. has distributed medical equipment. In the first quarter year 2019, has recognized from installation of Pneumatic Tube Carrier Systems 5 projects. And, Hi Healthcare
Ventures 1st Quarter 2019 MD&A 1 Indorama Ventures Public Company Ltd Management Discussion and Analysis 1st Quarter 2019 Highlights Revenue $3.0 billion (THB 95.8 billion), +26% YoY Core EBITDA of $304
Indorama Ventures 1st Quarter 2019 MD&A 1 Indorama Ventures Public Company Ltd Management Discussion and Analysis 1st Quarter 2019 Highlights Revenue $3.0 billion (THB 95.8 billion), +26% YoY Core EBITDA
to a 20% reduction in IVL’s core EBITDA. Operating cash flow through this period increased by 33% to $1.3B, as a result of lower prices and operational excellence. IVL has proposed a dividend of
growth driven by lifestyle fibers growth in India (IRSL). IVL reported US$281M of core EBITDA registering a more pronounced decline yoy as spreads came off from a strong 3Q18. IVL reported US$405M of OCF
THB 3.55 million or 12.72%. 4. Revenues from sea freight carrier Revenues ratio from sea freight carrier business in the fiscal year 2014 and 2013 was 0.77% and 1.08% respectively. revenue decreased due